Extracted from this filing and checked against the source text.
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Arcadia Biosciences, Inc. completed a disposition involving Pioneer Hi-Bred International, Inc. for $4,000,000 in cash (closed 2024-05-13).
- Action
- disposition
- Counterparty
- Pioneer Hi-Bred International, Inc.
- Consideration
- $4,000,000 in cash
- Closing
- 2024-05-13
Exact text from the filing
worked to introgress the resistant starch durum wheat trait into elite germplasm lines. As consideration for the sale and license of Purchased Assets, Pioneer paid to Arcadia $4,000,000 in cash, which consideration was determined based on negotiations between the parties. The Agreement includes a number customary provisions addressing matters such as closing
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.99
Arcadia Biosciences, Inc. entered into Asset Purchase Agreement with Pioneer Hi-Bred International, Inc. valued at $4,000,000 in cash (effective 2024-05-13).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Pioneer Hi-Bred International, Inc.
- Value
- $4,000,000 in cash
- Effective
- 2024-05-13
Exact text from the filing
On May 13, 2024, Arcadia Biosciences, Inc. (“Arcadia”) entered into an Asset Purchase Agreement (the “Agreement”) with Pioneer Hi-Bred International, Inc. (“Pioneer”), an indirect, wholly-owned subsidiary of Corteva, Inc., pursuant to which on May 13, 2024 Arcadia sold or licensed to Pioneer certain patent and related rights associated with Arcadia’s resistant starch durum wheat trait (“Purchased Assets”).
View on SEC.gov